AzTrials
AzTrials

ArthritisSBSvsLRTINCT05111405

Study Comparing SBS and LRTI for Treatment of CMC Arthritis

A study testing CMC Arthroplasty in people with Arthritis, run by Fraser Orthopaedic Research Society at 2 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
Conditions the study is for
Arthritis
What is being tested?
CMC Arthroplasty
Could I receive a placebo?
No, everyone receives an active treatment
How many people
138 participants
Where
2 sitesCanada
Study dates
20 Jun 2022to May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age fifty years or older
  • Isolated carpometacarpal (trapeziometacarpal) osteoarthritis
  • Failure to respond to non-operative management
  • Willing and able to consent on their own behalf and follow the protocol and clinical visits as described
  • Able to read and understand English or have interpreter available

Who cannot join

  • Previous surgery for CMC arthritis
  • Duration of symptoms for less than 6 months
  • Greater than or equal to 30 degrees of ipsilateral metacarpophalangeal (MCP) hyperextension
  • Scaphotrapeziotrapezoidal (stage 4 CMC) arthritis
  • Other significant ipsilateral wrist or hand pathology
  • A history of inflammatory arthropathy
Show all 9Show fewer
  • A requirement for concomitant surgery for another condition
  • Any previous hand or wrist fracture
  • Likely problems, in the judgement of the investigators, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged patients without adequate support, etc.)

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Bertrand Perey contact

604-553-3247

bperey@shaw.ca

Canada2 sites, 2 recruiting
  • South Campus Research Unit for Bone and Soft Tissue

    Calgary, Alberta, T3M1M4

    Neil White, 403-956-3687

    Adina Tarcea, 403-956-3687, shcorthoresearch@ucalgary.ca

    Recruiting
  • Fraser Orthopaedic Research Society

    New Westminster, British Columbia, V3L 0E4

    Bertrand Perey, MD, 604-553-3247

    Kyrsten Butterfield, BSc, 604-553-3247, kyrsten.butterfield@fraserhealth.ca

    Recruiting

Other trials in Canada

About this study

Official title: A Randomized Prospective Multicenter Study Comparing Suture Button Suspensionplasty (SBS) with Ligament Reconstruction and Tendon Interposition (LRTI)

A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Patient reported outcomes will be collected at 6 and 6 weeks, 3, 6, and 12 months.

Read the detailed description

LRTI is a well established treatment of CMC arthritis with good results.However, comparable results have also been reported with SBS, with the latter procedure eliminating the need for flexor carpi radialis (FCR) harvest and interposition, resulting in potential shorter OR time and donor site morbidity. To date, there have been biomechanical studies comparing LRTI vs suture button suspension arthroplasty (SBS), and clinical studies comparing trapeziectomy alone vs SBS, but to the best of our knowledge, no random control studies comparing LRTI with SBS.The primary objective is to determine whether treatment with SBS results in improved overall pain relief compared to LRTI as measured by patient reported outcomes.Secondary outcome measures will be to determine if SBS results in shorter OR time and improved grip and pinch strength compared to LRTI, as well as have comparable return to work times and amount of radiographic shortening as shown on radiographs (metacarpal shortening has been felt to lead to decreased grip strength).

Conditions
Arthritis
Being tested
CMC Arthroplasty
Medical subject headings
Arthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CMC ArthroplastyProcedure or surgery

    Surgical intervention to treat CMC arthritis

Study groups in NCT05111405
Study groupRoleWhat they receive
Trapezial excision with or without soft tissue interposition and /or ligament reconstructionOtherThe participating surgeon will perform their usual version of a trapeziectomy and thumb metacarpal using either FCR tendon or abductor hallucis longs (APL) tendon. Tendon interposition will be left to the surgeon's discretion.
Receives: Procedure: CMC Arthroplasty
Suture button suspension arthroplasty (SBS)OtherDorso-radial incision, capsulotomy between extensor pollicis brevis (EPB) and APL protecting the radial artery. A second incision is made on dorsum of hand between the 2nd and 3rd MCs. A cannulated drill with suture passer is passed from base of 1st MC to mid 2nd MC. The TightropeTM is passed from 1st to second MC with one button on the base of the 1st MC. Trapeziectomy is then performed using a cruciate osteotomy and rongeurs. The thumb is adducted against index MC to avoid excessive tightening and the suture is tied over a second button on the 2nd MC. Closure of capsule with Vicryl. Closure of skin with running Prolene suture.
Receives: Procedure: CMC Arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale- Pain

    Participants overall assessment of their pain at maximal key pinch loading on a 10 cm visual analogue scale

    Measured: 12 Months

  2. Disabilities of the Arm, Shoulder and Hand Questionnaire

    A 30 Item questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores will indicated better outcomes.Lower scores will indicate better outcomes.

    Measured: 12 Months

  3. Patient Related Wrist Evaluation Questionnaire

    A 15 item questionnaire to measure wrist pain and disability pain in activities of daily living

    Measured: 12 Months

Secondary outcomes (4)
  1. Operative Time

    Time as recorded from the surgeons start of the procedure until the surgeons stop.

    Measured: Intraoperative

  2. Strength

    Transverse volar grip strength as measured by a dynamometer and key and lateral pinch strength measure by a pinch gauge

    Measured: 12 Months

  3. Range of Motion

    Thumb flexion will be measured from the top of the thumb (pulp) to the base of the 5th metacarpal (pinky finger). Retropulsion measured as the distance between the thumb and table when the dorsum of the hand is pressed against the table.

    Measured: 12 Months

  4. Work Productivity and Activity Impairment: Specific Health Problem Questionnaire

    A questionnaire pertaining to the effect of the participant's CMC arthritis on their ability to work and perform regular activities. Lower scores will indicate better outcomes.

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2021
  2. Study start20 Jun 2022
  3. Primary completionFeb 2026 (estimated)
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Model description
Multicenter, randomized, prospective trial.
Masking
None (open label)
Enrolment
138 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05111405
Sponsor's protocol ID
FHREB # 2021-112
Acronym
SBSvsLRTI
Status last verified
Feb 2025
First submitted
27 Oct 2021
Last updated
28 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CMC Arthroplasty in people with Arthritis, run by Fraser Orthopaedic Research Society at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bertrand Perey (604-553-3247, bperey@shaw.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale- Pain (time frame: 12 Months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in